{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:47:43Z","timestamp":1790254063693,"version":"4.1.0"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01966","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:51:11Z","timestamp":1566471071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure"],"prefix":"10.3389","volume":"10","author":[{"given":"Nilu","family":"Goonetilleke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Clutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Swanstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e18889","DOI":"10.7554\/eLife.18889","article-title":"Establishment and stability of the latent HIV-1 DNA reservoir","volume":"5","author":"Brodin","year":"2016","journal-title":"eLife."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/512475","article-title":"The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation","author":"Abrahams","year":"2019","journal-title":"bioRxiv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1471-2105-14-255","article-title":"A multiple-alignment based primer design algorithm for genetically highly variable DNA targets","volume":"14","author":"Brodin","year":"2013","journal-title":"BMC Bioinformatics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"20166","DOI":"10.1073\/pnas.1110064108","article-title":"Accurate sampling and deep sequencing of the HIV-1 protease gene using a primer ID","volume":"108","author":"Jabara","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.1128\/JVI.00522-15","article-title":"Primer ID validates template sampling depth and greatly reduces the error rate of next-generation sequencing of HIV-1 genomic RNA populations","volume":"89","author":"Zhou","year":"2015","journal-title":"J Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1004010","DOI":"10.1371\/journal.ppat.1004010","article-title":"Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy","volume":"10","author":"Kearney","year":"2014","journal-title":"PLoS Pathog."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1172\/JCI94582","article-title":"No evidence of HIV replication in children on antiretroviral therapy","volume":"127","author":"Van Zyl","year":"2017","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"ofx173","DOI":"10.1093\/ofid\/ofx173","article-title":"Ongoing HIV replication during ART reconsidered","volume":"4","author":"Kearney","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.exphem.2016.06.003","article-title":"IL-2, IL-7, and IL-15: multistage regulators of CD4(+) T helper cell differentiation","volume":"44","author":"Read","year":"2016","journal-title":"Exp Hematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(18)32462-0","article-title":"GEMINI Study Team. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials","volume":"393","author":"Cahn","year":"2019","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S0140-6736(09)60918-1","article-title":"STARTMRK Investigators. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial","volume":"374","author":"Lennox","year":"2009","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1\u2013infected compartments during combination therapy","volume":"387","author":"Perelson","year":"1997","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1086\/317615","article-title":"Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection","volume":"182","author":"Blankson","year":"2000","journal-title":"J Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0186101","DOI":"10.1371\/journal.pone.0186101","article-title":"HIV dynamics linked to memory CD4+ T cell homeostasis","volume":"12","author":"Murray","year":"2017","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1073\/pnas.0800050105","article-title":"Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy","volume":"105","author":"Palmer","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1006478","DOI":"10.1371\/journal.ppat.1006478","article-title":"Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration","volume":"13","author":"Cardozo","year":"2017","journal-title":"PLoS Pathog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1097\/QAD.0000000000001255","article-title":"Duke-UNC Acute HIV Infection Consortium. Fixed-dose combination emtricitabine\/tenofovir\/efavirenz initiated during acute HIV infection; 96-week efficacy and durability","volume":"30","author":"Gay","year":"2016","journal-title":"AIDS."},{"key":"B20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11904-017-0356-x","article-title":"Inflammation, immune activation, and antiretroviral therapy in HIV","volume":"14","author":"Hileman","year":"2017","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Design of Ie, Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"E349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013:a collaborative analysis of cohort studies","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV."},{"key":"B23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tim.2015.01.013","article-title":"Towards an HIV-1 cure: measuring the latent reservoir","volume":"23","author":"Bruner","year":"2015","journal-title":"Trends Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1016\/S2352-3018(19)30053-0","article-title":"RV397 Study Group. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"6","author":"Crowell","year":"2019","journal-title":"Lancet HIV."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1128\/JVI.01046-14","article-title":"Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1\u2013infected CD4 T cells","volume":"88","author":"Buzon","year":"2014","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/infdis\/jiw172","article-title":"Diversity and tropism of HIV-1 rebound virus populations in plasma level after treatment discontinuation","volume":"214","author":"Bednar","year":"2016","journal-title":"J Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7383","DOI":"10.1128\/JVI.77.13.7383-7392.2003","article-title":"Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo","volume":"77","author":"Hermankova","year":"2003","journal-title":"J Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies","volume":"212","author":"Crooks","year":"2015","journal-title":"J Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jac\/dkh292","article-title":"A long-term latent reservoir for HIV-1:discovery and clinical implications","volume":"54","author":"Siliciano","year":"2004","journal-title":"J Antimicrob Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"Whitney","year":"2014","journal-title":"Nature."},{"key":"B37","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMc1413931","article-title":"Viremic relapse after HIV-1 remission in a perinatally infected child","volume":"372","author":"Luzuriaga","year":"2015","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1002417","DOI":"10.1371\/journal.pmed.1002417","article-title":"HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study","volume":"14","author":"Henrich","year":"2017","journal-title":"PLoS Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","article-title":"RV411 Study Group. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection","volume":"24","author":"Colby","year":"2018","journal-title":"Nat Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"Sogaard","year":"2015","journal-title":"PLoS Pathog."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1038\/ncomms6377","article-title":"Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2","volume":"5","author":"McKinstry","year":"2014","journal-title":"Nat Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature24633","article-title":"Origin and differentiation of human memory CD8 T cells after vaccination","volume":"552","author":"Akondy","year":"2017","journal-title":"Nature."},{"key":"B43","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.1128\/JVI.72.10.8281-8288.1998","article-title":"Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection","volume":"72","author":"Whitmire","year":"1998","journal-title":"J Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature06672","article-title":"Memory CD4 T cells emerge from effector T-cell progenitors","volume":"452","author":"Harrington","year":"2008","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.immuni.2009.05.006","article-title":"Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells","volume":"30","author":"Araki","year":"2009","journal-title":"Immunity."},{"key":"B46","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2017.03.012","article-title":"Polycomb repressive complex 2-mediated chromatin repression guides effector CD8(+) T cell terminal differentiation and loss of multipotency","volume":"46","author":"Gray","year":"2017","journal-title":"Immunity."},{"key":"B47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/imr.12693","article-title":"Current best estimates for the average lifespans of mouse and human leukocytes: reviewing two decades of deuterium-labeling experiments","volume":"285","author":"Borghans","year":"2018","journal-title":"Immunol Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2005523","DOI":"10.1371\/journal.pbio.2005523","article-title":"Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemness","volume":"16","author":"Costa Del Amo","year":"2018","journal-title":"PLoS Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1086\/592716","article-title":"Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy","volume":"198","author":"Benito","year":"2008","journal-title":"J Infect Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ni946","article-title":"Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells","volume":"4","author":"Seddon","year":"2003","journal-title":"Nat Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.20030735","article-title":"Interleukin 7 regulates the survival and generation of memory CD4 cells","volume":"198","author":"Kondrack","year":"2003","journal-title":"J Exp Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1084\/jem.20030725","article-title":"IL-7 promotes the transition of CD4 effectors to persistent memory cells","volume":"198","author":"Li","year":"2003","journal-title":"J Exp Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.1038\/s41598-017-11926-2","article-title":"Peripheral human CD4(+)CD8(+) T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15","volume":"7","author":"Clenet","year":"2017","journal-title":"Sci Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1172\/JCI66327","article-title":"Superior T memory stem cell persistence supports long-lived T cell memory","volume":"123","author":"Lugli","year":"2013","journal-title":"J Clin Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1084\/jem.20062381","article-title":"Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells","volume":"204","author":"Dooms","year":"2007","journal-title":"J Exp Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.4049\/jimmunol.174.5.2900","article-title":"Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals","volume":"174","author":"Paiardini","year":"2005","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"10285","DOI":"10.1038\/ncomms10285","article-title":"IL-7 signalling represses Bcl-6 and the TFH gene program","volume":"7","author":"McDonald","year":"2016","journal-title":"Nat Commun."},{"key":"B62","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/eji.200535111","article-title":"IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation","volume":"36","author":"Koesters","year":"2006","journal-title":"Eur J Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.1128\/JVI.00249-06","article-title":"Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection","volume":"80","author":"Zaunders","year":"2006","journal-title":"J Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2012.09.020","article-title":"Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets","volume":"38","author":"Sathaliyawala","year":"2013","journal-title":"Immunity."},{"key":"B65","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.4049\/jimmunol.167.12.6869","article-title":"IL-7 enhances the survival and maintains the size of naive T cells","volume":"167","author":"Rathmell","year":"2001","journal-title":"J Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ni834","article-title":"Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis","volume":"3","author":"Rathmell","year":"2002","journal-title":"Nat Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2004.07.016","article-title":"Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7\u2013dependent T cell survival","volume":"21","author":"Park","year":"2004","journal-title":"Immunity."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1182\/blood-2009-10-246876","article-title":"IL-7 induces rapid clathrin-mediated internalization and JAK3\u2013dependent degradation of IL-7Ralpha in T cells","volume":"115","author":"Henriques","year":"2010","journal-title":"Blood."},{"key":"B70","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","article-title":"Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens","volume":"26","author":"Dudley","year":"2008","journal-title":"J Clin Oncol."},{"key":"B71","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1128\/JVI.71.6.4436-4444.1997","article-title":"Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI","volume":"71","author":"Chun","year":"1997","journal-title":"J Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1073\/pnas.96.9.5215","article-title":"Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages","volume":"96","author":"Lee","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B73","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.celrep.2017.06.087","article-title":"Mass cytometric analysis of HIV entry, replication, and remodeling in tissue CD4+ T cells","volume":"20","author":"Cavrois","year":"2017","journal-title":"Cell Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.celrep.2018.09.020","article-title":"Single-cell analysis of quiescent HIV infection reveals host transcriptional profiles that regulate proviral latency","volume":"25","author":"Bradley","year":"2018","journal-title":"Cell Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.immuni.2017.09.014","article-title":"Transcriptional reprogramming during effector-to-memory transition renders CD4(+) T cells permissive for latent HIV-1 infection","volume":"47","author":"Shan","year":"2017","journal-title":"Immunity."},{"key":"B76","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nm0295-129","article-title":"Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes","volume":"1","author":"Finkel","year":"1995","journal-title":"Nat Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"13778","DOI":"10.1073\/pnas.250472097","article-title":"Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients","volume":"97","author":"Lempicki","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1128\/JVI.02785-15","article-title":"Expansion of inefficient HIV-specific CD8 T cells during acute infection","volume":"90","author":"Eller","year":"2016","journal-title":"J Virol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00042560-200108010-00010","article-title":"Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection","volume":"27","author":"Leng","year":"2001","journal-title":"J Acq Immune Defic Syndr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.1128\/JVI.75.20.9983-9985.2001","article-title":"Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease","volume":"75","author":"Sieg","year":"2001","journal-title":"J Virol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1172\/JCI200317533","article-title":"Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection","volume":"112","author":"Hellerstein","year":"2003","journal-title":"J Clin Invest."},{"key":"B82","doi-asserted-by":"publisher","first-page":"15572","DOI":"10.1073\/pnas.242358099","article-title":"In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?","volume":"99","author":"Ribeiro","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B83","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1128\/JVI.01635-06","article-title":"Loss of naive cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques","volume":"81","author":"Nishimura","year":"2007","journal-title":"J Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/infdis\/jir507","article-title":"Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells","volume":"204","author":"Lederman","year":"2011","journal-title":"J Infect Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/JVI.01475-09","article-title":"Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK\/STAT5 pathway","volume":"84","author":"Juffroy","year":"2010","journal-title":"J Virol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1097\/01.aids.0000189848.75699.0f","article-title":"Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients","volume":"19","author":"Rethi","year":"2005","journal-title":"AIDS."},{"key":"B87","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.tim.2008.08.011","article-title":"Loss of CD127 expression links immune activation and CD4(+) T cell loss in HIV infection","volume":"16","author":"Kiazyk","year":"2008","journal-title":"Trends Microbiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/infdis\/jiu125","article-title":"Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7:implications for immune failure in HIV disease","volume":"210","author":"Shive","year":"2014","journal-title":"J Infect Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1086\/499309","article-title":"Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection","volume":"193","author":"Sasson","year":"2006","journal-title":"J Infect Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1084\/jem.194.12.1731","article-title":"Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV","volume":"194","author":"Kovacs","year":"2001","journal-title":"J Exp Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1097\/01.aids.0000242819.72839.db","article-title":"Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART","volume":"20","author":"Marchetti","year":"2006","journal-title":"AIDS."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI16413","article-title":"Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis","volume":"110","author":"Schacker","year":"2002","journal-title":"J Clin Invest."},{"key":"B93","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1172\/JCI45157","article-title":"Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections","volume":"121","author":"Zeng","year":"2011","journal-title":"J Clin Invest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e1002437","DOI":"10.1371\/journal.ppat.1002437","article-title":"Lymphoid tissue damage in HIV-1 infection depletes naive T cells and limits T cell reconstitution after antiretroviral therapy","volume":"8","author":"Zeng","year":"2012","journal-title":"PLoS Pathog."},{"key":"B95","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.qai.0000214823.11034.4e","article-title":"Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients\u2013effects of antiretroviral therapy","volume":"42","author":"Colle","year":"2006","journal-title":"J Acq Immune Defic Syndr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.4049\/jimmunol.180.8.5582","article-title":"CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection","volume":"180","author":"Dunham","year":"2008","journal-title":"J Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"11348","DOI":"10.1073\/pnas.95.19.11348","article-title":"Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy","volume":"95","author":"David","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e31148","DOI":"10.1371\/journal.pone.0031148","article-title":"Progressive activation of CD127+132\u2212 recent thymic emigrants into terminally differentiated CD127\u2212132+ T-cells in HIV-1 infection","volume":"7","author":"Sasson","year":"2012","journal-title":"PLoS ONE."},{"key":"B99","doi-asserted-by":"publisher","first-page":"13904","DOI":"10.1128\/JVI.01401-07","article-title":"Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study","volume":"81","author":"Potter","year":"2007","journal-title":"J Virol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1073\/pnas.251539598","article-title":"High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation","volume":"98","author":"McNeil","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B101","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1164\/rccm.201108-1548OC","article-title":"A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and\/or Mycobacterium tuberculosis-infected adults","volume":"185","author":"Scriba","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40121-017-0165-y","article-title":"Vaccinations for the HIV-infected adult: a review of the current recommendations, part II","volume":"6","author":"Crum-Cianflone","year":"2017","journal-title":"Infect Dis Ther."},{"key":"B103","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40121-017-0166-x","article-title":"Vaccinations for the HIV-infected adult: a review of the current recommendations, part I","volume":"6","author":"Crum-Cianflone","year":"2017","journal-title":"Infect Dis Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1084\/jem.194.9.1277","article-title":"Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy","volume":"194","author":"Mohri","year":"2001","journal-title":"J Exp Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/labmed\/lmw053","article-title":"CD127 expression in naive and memory T cells in HIV patients who have undergone long-term HAART","volume":"48","author":"Xu","year":"2017","journal-title":"Lab Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/QAI.0000000000000913","article-title":"Inflammation perturbs the IL-7 axis, promoting senescence and exhaustion that broadly characterize immune failure in treated HIV infection","volume":"71","author":"Shive","year":"2016","journal-title":"J Acq Immune Defic Syndr."},{"key":"B107","doi-asserted-by":"publisher","first-page":"19851","DOI":"10.1073\/pnas.0810032105","article-title":"HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells","volume":"105","author":"Catalfamo","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B108","doi-asserted-by":"publisher","first-page":"96228","DOI":"10.1172\/jci.insight.96228","article-title":"IL-7\u2013dependent STAT1 activation limits homeostatic CD4+ T cell expansion","volume":"2","author":"Le Saout","year":"2017","journal-title":"JCI Insight."},{"key":"B109","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1128\/JVI.76.12.5925-5936.2002","article-title":"Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1\u2013specific lymphoproliferation in HIV-1\u2013infected subjects with active viral replication","volume":"76","author":"Palmer","year":"2002","journal-title":"J Virol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"127113","DOI":"10.1172\/jci.insight.127113","article-title":"Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression","volume":"4","author":"Lisco","year":"2019","journal-title":"JCI Insight."},{"key":"B111","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1038\/s41467-018-06804-y","article-title":"IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates","volume":"9","author":"Belarif","year":"2018","journal-title":"Nat Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1172\/JCI66287","article-title":"IL-7 receptor blockade following T cell depletion promotes long-term allograft survival","volume":"124","author":"Mai","year":"2014","journal-title":"J Clin Invest."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/art.24754","article-title":"Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis","volume":"60","author":"Hartgring","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1002\/art.27578","article-title":"Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators","volume":"62","author":"Hartgring","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1172\/JCI121668","article-title":"IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease","volume":"130","author":"Belarif","year":"2019","journal-title":"J Clin Invest."},{"key":"B116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molimm.2016.09.017","article-title":"Blockade of IL-7Ralpha alleviates collagen-induced arthritis via inhibiting Th1 cell differentiation and CD4(+) T cell migration","volume":"79","author":"Cai","year":"2016","journal-title":"Mol Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"12674","DOI":"10.1073\/pnas.1203795109","article-title":"Anti-IL-7 receptor-alpha reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B118","doi-asserted-by":"publisher","first-page":"12668","DOI":"10.1073\/pnas.1203692109","article-title":"IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector\/memory T cells","volume":"109","author":"Penaranda","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e0214379","DOI":"10.1371\/journal.pone.0214379","article-title":"Combining anti-IL-7Ralpha antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 diabetes","volume":"14","author":"Vazquez-Mateo","year":"2019","journal-title":"PLoS ONE."},{"key":"B120","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bcp.13748","article-title":"Anti-IL-7 receptor alpha monoclonal antibody (GSK2618960) in healthy subjects\u2013a randomized, double-blind, placebo-controlled study","volume":"85","author":"Ellis","year":"2019","journal-title":"Br J Clin Pharmacol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1182\/blood-2015-05-645077","article-title":"Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia","volume":"127","author":"Sheikh","year":"2016","journal-title":"Blood."},{"key":"B122","doi-asserted-by":"publisher","first-page":"98960","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e1003890","DOI":"10.1371\/journal.ppat.1003890","article-title":"Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration","volume":"10","author":"Sereti","year":"2014","journal-title":"PLoS Pathog."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1182\/blood-2012-11-465625","article-title":"Interleukin-7 promotes HIV persistence during antiretroviral therapy","volume":"121","author":"Vandergeeten","year":"2013","journal-title":"Blood."},{"key":"B125","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/cid\/cis383","article-title":"Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I\/IIa randomized, placebo-controlled, multicenter study","volume":"55","author":"Levy","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/cid\/ciw065","article-title":"Repeated cycles of recombinant human interleukin 7 in HIV-infected patients with low CD4 T-cell reconstitution on antiretroviral therapy: results of 2 phase II multicenter studies","volume":"62","author":"Thiebaut","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4049\/jimmunol.1601254","article-title":"Effect of IL-7 therapy on phospho-ribosomal protein S6 and TRAF1 expression in HIV-specific CD8 T cells in patients receiving antiretroviral therapy","volume":"200","author":"Wang","year":"2018","journal-title":"J Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/QAD.0000000000000894","article-title":"EraMune-01 Study Team. Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial","volume":"30","author":"Katlama","year":"2016","journal-title":"AIDS."},{"key":"B129","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1074\/jbc.M114.598631","article-title":"Interleukin 7 up-regulates CD95 protein on CD4+ T cells by affecting mRNA alternative splicing: priming for a synergistic effect on HIV-1 reservoir maintenance","volume":"290","author":"Yin","year":"2015","journal-title":"J Biol Chem."},{"key":"B130","first-page":"F-5","volume-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV","year":""},{"key":"B131","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/15284336.2017.1282578","article-title":"T. California Collaborative Treatment Group 589 Study. HIV viral kinetics and T cell dynamics in antiretroviral naive persons starting an integrase strand transfer inhibitor and protease inhibitor regimen","volume":"18","author":"Karris","year":"2017","journal-title":"HIV Clin Trials."},{"key":"B132","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1182\/blood-2010-12-323600","article-title":"Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance","volume":"118","author":"Hodge","year":"2011","journal-title":"Blood."},{"key":"B133","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coi.2016.02.006","article-title":"Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection","volume":"40","author":"Zhukovsky","year":"2016","journal-title":"Curr Opin Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"E8958","DOI":"10.1073\/pnas.1802028115","article-title":"Phylogenetic approach to recover integration dates of latent HIV sequences within-host","volume":"115","author":"Jones","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B135","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J Exp Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1172\/JCI64314","article-title":"Expansion of HIV-specific T follicular helper cells in chronic HIV infection","volume":"122","author":"Lindqvist","year":"2012","journal-title":"J Clin Invest."},{"key":"B138","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e1007619","DOI":"10.1371\/journal.ppat.1007619","article-title":"Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection","volume":"15","author":"Pardons","year":"2019","journal-title":"PLoS Pathog."},{"key":"B140","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/1471-2334-10-318","article-title":"Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study","volume":"10","author":"Engsig","year":"2010","journal-title":"BMC Infect Dis."},{"key":"B141","doi-asserted-by":"publisher","first-page":"314849","DOI":"10.1155\/2012\/314849","article-title":"Reduced central memory CD4+ T cells and increased T-cell activation characterise treatment-naive patients newly diagnosed at late stage of HIV infection","volume":"2012","author":"Bai","year":"2012","journal-title":"AIDS Res Treat."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/QAI.0000000000001397","article-title":"Initiation of antiretroviral therapy containing integrase inhibitors increases the risk of IRIS requiring hospitalization","volume":"76","author":"Dutertre","year":"2017","journal-title":"J Acq Immune Def Syndr."},{"key":"B143","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1570162X15666171122155708","article-title":"Integrase strand transfer inhibitors and the emergence of immune reconstituion inflammatory syndrom (IRIS)","volume":"15","author":"Psichogiou","year":"2017","journal-title":"Curr HIV Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1172\/JCI5863","article-title":"Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues","volume":"103","author":"Bucy","year":"1999","journal-title":"J Clin Invest."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e00430","DOI":"10.1128\/JVI.00430-17","article-title":"Follicular regulatory T cells are highly permissive to R5-tropic HIV-1","volume":"91","author":"Miller","year":"2017","journal-title":"J Virol."},{"key":"B146","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S2055-6640(20)30305-8","article-title":"Regulatory T cells: the ultimate HIV reservoir?","volume":"4","author":"Rocco","year":"2018","journal-title":"J Virus Erad."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/infdis\/jiq073","article-title":"Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy","volume":"203","author":"Montes","year":"2011","journal-title":"J Infect Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2016.01.006","article-title":"Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression","volume":"44","author":"Kloverpris","year":"2016","journal-title":"Immunity."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.20170518","article-title":"IL-7\u2013dependent maintenance of ILC3s is required for normal entry of lymphocytes into lymph nodes","volume":"215","author":"Yang","year":"2018","journal-title":"J Exp Med."},{"key":"B151","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.4319","article-title":"HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy","volume":"23","author":"Honeycutt","year":"2017","journal-title":"Nat Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1111\/jcmm.13610","article-title":"IL-7 suppresses macrophage autophagy and promotes liver pathology in Schistosoma japonicum-infected mice","volume":"22","author":"Zhu","year":"2018","journal-title":"J Cell Mol Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e1005201","DOI":"10.1371\/journal.ppat.1005201","article-title":"Peripheral Vgamma9Vdelta2 T cells are a novel reservoir of latent HIV infection","volume":"11","author":"Soriano-Sarabia","year":"2015","journal-title":"PLoS Pathog."},{"key":"B154","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1038\/s41467-018-06843-5","article-title":"A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation","volume":"9","author":"Reeves","year":"2018","journal-title":"Nat Commun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T06:07:14Z","timestamp":1610863634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":154,"alternative-id":["10.3389\/fimmu.2019.01966"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01966","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"article-number":"1966"}}